Notice of extraordinary general meeting
Filed with HKEX · Stock code 6667 · · 2 pages · English
Summary by 6ix AI
Mega Genomics Limited has issued a notice for an extraordinary general meeting to be held in Beijing. The meeting will consider a proposed revision of the annual cap under a genetic testing service framework agreement. Shareholders will vote on whether to approve the increase in the annual cap from a specified amount to a higher amount.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Mega Genomics
- Continuing connected transactions - proposed revision of the 2026 annual cap under the 2024 meinian framework agreement and notice of extraordinary general meeting
- Supplemental announcement in relation to the interim results for the six months ended 30 June 2026
- Delay in despatch of circular - continuing connected transactions - proposed revision of the 2026 annual cap under the 2024 meinian framework agreement
- Next Day Disclosure Returns
- Continuing connected transactions - renewal of the meinian cooperation framework agreement and the dr. yu cooperation framework agreement
Later from Mega Genomics
- Form of proxy for the extraordinary general meeting to be held on 27 November 2026
- Documents on Display
Follow Mega Genomics into a list and get an email when it puts out news.
Follow Mega Genomics